Clinical Trial Detail

NCT ID NCT04099797
Title C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Baylor College of Medicine
Indications

brain stem glioma

malignant glioma

Therapies

C7R-GD2.CART cells

Cyclophosphamide + Fludarabine

Age Groups: child adult

No variant requirements are available.